胸腔内注射斯奇康佐治结核性胸膜炎的研究

目的　观察斯奇康注射液胸腔内注射后结核性胸膜炎胸水吸收速度、症状控制时间、后期胸膜肥厚粘连发生率。方法　随机抽样分为治疗组和对照组。治疗组在全身化疗的基础上予斯奇康注射液胸膜腔注入。对照组未应用斯奇康注射液。结果　 2组近期疗效有差异 ,显效率治疗组为 81% ,对照组为 5 8% ,P <0 .0 5 ;有效率治疗组与对照组分别为 19%和 4 2 % ,总有效率 2组均为 10 0 %。胸膜增厚率治疗组为 11% ,对照组为 2 4 % ,P <0 .0 5。结论　斯奇康注射液胸膜腔内注入对结核性胸膜炎有较大临床治疗价值。

Study of BCG-PSN injected into pleural cavity for assisting to treat tuberculo-pleurisy

Objective It is to observe hydrothorax absorption ve lo city, symptom controlled time and anaphase pleura pachynsis conglutination occur ring rate of tub erculo-pleurisy after BCG-PSN injected into pleural cavity.Methods The cases were randomly chosen and divided into treatment group and cont rol group. The treatment group was given BCG-PSN injected into pleural cavity b ased on systemic chemical treatment. The control group was not given BCG-PSN.Results There was significant difference at curative effect betwee n the two grou ps. The obvious effective rate in treatment group was 81% and that in control gr oup was 58%, P<0.05. The effective rate in treatment group was 19% and that in c ontrol group was 42%. The total effective rates in the two groups were both 100% . The pleura pachynsis rate in treatment group was 11% and that in control group was 24%, P<0.05.Conclusion BCG-PSN injected into pleural cavity has biggish clini cal treatment value on tuberculo-pleurisy.